Finance

Lists
VYGR:NASDAQ
Voyager Therapeutics Inc
$ 2.46
+0.41%
(+0.0100) 1D
$ 2.47
+0.41% (+0.0100)
Pre-market
Closed: 10-р сарын 5, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VYGR...
Open
$ 2.43
High
$ 2.55
Low
$ 2.39
Mkt. cap
151.58 сая
Avg. vol.
513.42 мян
Volume
1.80 мян
52-wk high
$ 5.55
52-wk low
$ 2.39
EPS
-$ 1.81
Beta
1.29
Shares outstanding
61.62 сая
No. of employees
141
Open
$ 2.43
High
$ 2.55
Low
$ 2.39
Mkt. cap
151.58 сая
Avg. vol.
513.42 мян
Volume
1.80 мян
52-wk high
$ 5.55
52-wk low
$ 2.39
EPS
-$ 1.81
Beta
1.29
Shares outstanding
61.62 сая
No. of employees
141
News stories
From web sources and news partners
About Voyager Therapeutics Inc
CEO-
Employees141
Founded2013
HeadquartersLexington, Массачусеттс, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to VYGR in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for VYGR in the last 3 months.
Highest
Current $ 2.46
$ 25.00 (+916.26%)
Average
$ 13.75 (+458.94%)
Lowest
$ 8.00 (+225.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wells Fargo
Buy
Maintained
$ 10.00
+306.5%
10/02/2026
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
$ 25.00
+916.3%
09/21/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$ 12.00
+387.8%
08/12/2026
Yun Zhong
Wedbush
Buy
Maintained
$ 8.00
+225.2%
08/07/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/06/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
$ 22.00
+794.3%
06/02/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$ 18.00
+631.7%
05/08/2026
Samantha Semenkow
Citi
Buy
Reiterated
$ 11.00
+347.2%
03/23/2026
Joon Lee
Truist Financial
Buy
Maintained
-
-
03/17/2026
Last report
2026 оны 8-р сарын 6
Fiscal period
Q2 2026
EPS / Est. (USD)
-$ 0.40 / -$ 0.51
+21.22%beat
Revenue / Est. (USD)
3.16 сая / 4.56 сая
-30.64%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
13.36 сая
15.34 сая
2.59 сая
3.16 сая
Cost of goods sold
35.87 сая
33.55 сая
24.60 сая
22.04 сая
Cost of revenue
35.87 сая
33.55 сая
24.60 сая
22.04 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.09 сая
8.22 сая
8.26 сая
7.52 сая
Operating expense
8.09 сая
8.22 сая
8.26 сая
7.52 сая
Total operating expenses
43.96 сая
41.77 сая
32.86 сая
29.56 сая
Operating income
-30.59 сая
-26.43 сая
-30.27 сая
-26.39 сая
Other non operating income
400.00 мян
404.00 мян
435.00 мян
411.00 мян
EBT including unusual items
-27.81 сая
-27.42 сая
-27.92 сая
-24.45 сая
EBT excluding unusual items
-27.81 сая
-23.92 сая
-27.92 сая
-24.45 сая
Income tax expense
83.00 мян
9.00 мян
14.00 мян
20.00 мян
Effective tax rate
-0.30%
-0.03%
-0.05%
-0.08%
Other operating expenses
-
-
-
-
Net income
-27.89 сая
-27.43 сая
-27.94 сая
-24.47 сая
Net profit margin
-208.69%
-178.83%
-1,077.40%
-773.24%
Earnings per share
-0.47
-0.47
-0.47
-0.40
Interest and investment income
2.38 сая
2.11 сая
1.91 сая
1.53 сая
Interest expense
-
-
-
-
Net interest expenses
2.38 сая
2.11 сая
1.91 сая
1.53 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-29.66 сая
-25.38 сая
-29.34 сая
-25.48 сая
Gain or loss from assets sale
-
62.00 мян
-
105.00 мян
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс